Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 10 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2026 Filed Feb 3, 2026 21:44 UTC |
Skyler JenniferChief Corp. Affairs Officer
|
GrantCommon Stock | 9,952 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000004962-26-000069 · form4.xml · nonDerivative · entry 1 Skyler Jennifer · CIK 0001793965 · Chief Corp. Affairs Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,835.762 F1 · kind: Represents shares acquired pursuant to the vesting of Performance Restricted Stock Units that were granted to the reporting person in February 2023, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment. F1 · price: Represents shares acquired pursuant to the vesting of Performance Restricted Stock Units that were granted to the reporting person in February 2023, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:46 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 74,129 | $0.00 Strike: $173.61 | $0.00 |
DisclosureSEC source: 0000004962-26-000070 · form4.xml · derivative · entry 5 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,129 Underlying: Common Stock · 74,129 shares Expires 2033-02-01 F5 · kind: Represents the vesting of Performance Stock Options that were granted to the reporting person in February 2023, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:46 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 62,466 | $352.17 | $21,998,651.22 |
DisclosureSEC source: 0000004962-26-000070 · form4.xml · nonDerivative · entry 2 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 60,567 F3 · kind: The reported disposition represents the surrender of shares to satisfy tax obligations arising from the vesting of Performance Restricted Stock Units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:46 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
GrantCommon Stock | 123,033 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000004962-26-000070 · form4.xml · nonDerivative · entry 1 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,033 F1 · kind: Represents shares acquired pursuant to the vesting of Performance Restricted Stock Units that were granted to the reporting person in February 2023, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment. F1 · price: Represents shares acquired pursuant to the vesting of Performance Restricted Stock Units that were granted to the reporting person in February 2023, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment. F2 · balance_after: Balance reflects the prior transfer of 163,292.479 shares from the reporting person's direct holdings to the Stephen J. Squeri 2025 Master GRAT, which is exempt from Section 16 pursuant to Rule 16a-13. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:47 UTC |
Tabish DouglasChief Risk Officer
|
Tax withholdingCommon Stock | 4,425 | $352.17 | $1,558,352.25 |
DisclosureSEC source: 0000004962-26-000071 · form4.xml · nonDerivative · entry 2 Tabish Douglas · CIK 0002021720 · Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,594 F2 · kind: The reported disposition represents the surrender of shares to satisfy tax obligations arising from the vesting of Performance Restricted Stock Units. Read SEC document |
| February 01, 2026 Filed Feb 3, 2026 21:47 UTC |
Tabish DouglasChief Risk Officer
|
GrantCommon Stock | 9,504 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000004962-26-000071 · form4.xml · nonDerivative · entry 1 Tabish Douglas · CIK 0002021720 · Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,019 F1 · kind: Represents shares acquired pursuant to the vesting of Performance Restricted Stock Units that were granted to the reporting person in February 2023, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment. F1 · price: Represents shares acquired pursuant to the vesting of Performance Restricted Stock Units that were granted to the reporting person in February 2023, based upon the satisfaction of performance criteria specified for the award at the time of grant and the reporting person's continued employment. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:04 UTC |
Angelakis Michael JDirector
|
GrantShare Equivalent Units · Derivative | 23.933 | $378.66 | $9,062.47 |
DisclosureSEC source: 0000004962-26-000012 · form4.xml · derivative · entry 1 Angelakis Michael J · CIK 0001393014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,045.23 Underlying: Common Stock · 23.933 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:07 UTC |
Baltimore Thomas J JrDirector
|
GrantShare Equivalent Units · Derivative | 95.732 | $378.66 | $36,249.88 |
DisclosureSEC source: 0000004962-26-000014 · form4.xml · derivative · entry 1 Baltimore Thomas J Jr · CIK 0001390946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,362.699 Underlying: Common Stock · 95.732 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:10 UTC |
Brennan John JosephDirector
|
GrantShare Equivalent Units · Derivative | 174.959 | $378.66 | $66,249.97 |
DisclosureSEC source: 0000004962-26-000016 · form4.xml · derivative · entry 1 Brennan John Joseph · CIK 0001485472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,178.009 Underlying: Common Stock · 174.959 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:12 UTC |
Majoras Deborah PDirector
|
GrantShare Equivalent Units · Derivative | 47.867 | $378.66 | $18,125.32 |
DisclosureSEC source: 0000004962-26-000018 · form4.xml · derivative · entry 1 Majoras Deborah P · CIK 0001483177 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,246.726 Underlying: Common Stock · 47.867 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:15 UTC |
PHILLIPS JR CHARLES EDirector
|
GrantShare Equivalent Units · Derivative | 99.034 | $378.66 | $37,500.21 |
DisclosureSEC source: 0000004962-26-000020 · form4.xml · derivative · entry 1 PHILLIPS JR CHARLES E · CIK 0001236185 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,589.615 Underlying: Common Stock · 99.034 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:18 UTC |
VASELLA DANIELDirector
|
GrantShare Equivalent Units · Derivative | 92.431 | $378.66 | $34,999.92 |
DisclosureSEC source: 0000004962-26-000022 · form4.xml · derivative · entry 1 VASELLA DANIEL · CIK 0001189152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,854.26 Underlying: Common Stock · 92.431 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:21 UTC |
WARDELL LISA WDirector
|
GrantShare Equivalent Units · Derivative | 99.033 | $378.66 | $37,499.84 |
DisclosureSEC source: 0000004962-26-000024 · form4.xml · derivative · entry 1 WARDELL LISA W · CIK 0001450092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,395.782 Underlying: Common Stock · 99.033 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 31, 2025 Filed Jan 5, 2026 21:23 UTC |
Young Christopher DavidDirector
|
GrantShare Equivalent Units · Derivative | 105.636 | $378.66 | $40,000.13 |
DisclosureSEC source: 0000004962-26-000026 · form4.xml · derivative · entry 1 Young Christopher David · CIK 0001647655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,891.099 Underlying: Common Stock · 105.636 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 21:06 UTC |
Joabar RaymondGrp. Pres., Global Comm. Serv.
|
GiftCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-25-000268 · form4.xml · nonDerivative · entry 2 Joabar Raymond · CIK 0001788395 · Grp. Pres., Global Comm. Serv. 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 1,486.996 F3 · shares: Reflects the gift of common stock to a charitable donor advised fund. F2 · balance_after: Includes shares acquired pursuant to dividend reinvestment. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 21:06 UTC |
Joabar RaymondGrp. Pres., Global Comm. Serv.
|
SaleCommon Stock | 1,400 | $384.93 | $538,902.00 |
DisclosureSEC source: 0000004962-25-000268 · form4.xml · nonDerivative · entry 1 Joabar Raymond · CIK 0001788395 · Grp. Pres., Global Comm. Serv. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,417.026 F1 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $384.80 to $384.95. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. F2 · balance_after: Includes shares acquired pursuant to dividend reinvestment. Read SEC document |
| December 04, 2025 Filed Dec 8, 2025 21:06 UTC |
Buckminster Douglas E.Vice Chairman
|
GiftCommon Stock | 13,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-25-000262 · form4.xml · nonDerivative · entry 1 Buckminster Douglas E. · CIK 0001477675 · Vice Chairman 10b5-1 filing: No plan indicated Ownership: Indirect · By The Douglas E. Buckminster Grantor Retained Annuity Trust Agreement Disclosed balance after: 0 F1 · balance_after: Balance reflects the transfer of 7,716 shares from The Douglas E. Buckminster Grantor Retained Annuity Trust Agreement to the reporting person as an annuity payment, which is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| November 03, 2025 Filed Nov 4, 2025 21:20 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
GiftCommon Stock | 10,688 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-25-000252 · form4.xml · nonDerivative · entry 1 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 163,292 F1 · kind: Reflects the gift of common stock to a charitable donor advised fund. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:09 UTC |
Grosfield HowardGroup Pres., U.S. Cons. Serv.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 52,395 | $0.00 Strike: $148.45 | $0.00 |
DisclosureSEC source: 0000004962-25-000245 · form4.xml · derivative · entry 1 Grosfield Howard · CIK 0001957990 · Group Pres., U.S. Cons. Serv. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,395 Underlying: Common Stock · 52,395 shares Expires 2029-10-31 F1 · kind: Represents shares acquired pursuant to vesting of Performance Stock Option (Options) that were granted to the reporting person in October 2022, 75% of which have vested based upon the satisfaction of performance criteria specified for the award at time of grant. The remaining 25% of the Options remain subject to the satisfaction of performance criteria and the reporting person's continued employment through October 31, 2026. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:11 UTC |
Herena MoniqueChief Colleague Exp. Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 52,395 | $0.00 Strike: $148.45 | $0.00 |
DisclosureSEC source: 0000004962-25-000246 · form4.xml · derivative · entry 1 Herena Monique · CIK 0001606897 · Chief Colleague Exp. Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,395 Underlying: Common Stock · 52,395 shares Expires 2029-10-31 F1 · kind: Represents shares acquired pursuant to vesting of Performance Stock Option (Options) that were granted to the reporting person in October 2022, 75% of which have vested based upon the satisfaction of performance criteria specified for the award at time of grant. The remaining 25% of the Options remain subject to the satisfaction of performance criteria and the reporting person's continued employment through October 31, 2026. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:12 UTC |
Joabar RaymondGrp. Pres., Global Comm. Serv.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 67,365 | $0.00 Strike: $148.45 | $0.00 |
DisclosureSEC source: 0000004962-25-000247 · form4.xml · derivative · entry 1 Joabar Raymond · CIK 0001788395 · Grp. Pres., Global Comm. Serv. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,365 Underlying: Common Stock · 67,365 shares Expires 2029-10-31 F1 · kind: Represents shares acquired pursuant to vesting of Performance Stock Option (Options) that were granted to the reporting person in October 2022, 75% of which have vested based upon the satisfaction of performance criteria specified for the award at time of grant. The remaining 25% of the Options remain subject to the satisfaction of performance criteria and the reporting person's continued employment through October 31, 2026. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:16 UTC |
Pickett DenisePres., Enterprise Shared Serv.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 52,395 | $0.00 Strike: $148.45 | $0.00 |
DisclosureSEC source: 0000004962-25-000249 · form4.xml · derivative · entry 1 Pickett Denise · CIK 0001730101 · Pres., Enterprise Shared Serv. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,395 Underlying: Common Stock · 52,395 shares Expires 2029-10-31 F1 · kind: Represents shares acquired pursuant to vesting of Performance Stock Option (Options) that were granted to the reporting person in October 2022, 75% of which have vested based upon the satisfaction of performance criteria specified for the award at time of grant. The remaining 25% of the Options remain subject to the satisfaction of performance criteria and the reporting person's continued employment through October 31, 2026. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:14 UTC |
Marrs AnnaGroup Pres., GMNS
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 67,365 | $0.00 Strike: $148.45 | $0.00 |
DisclosureSEC source: 0000004962-25-000248 · form4.xml · derivative · entry 1 Marrs Anna · CIK 0001753557 · Group Pres., GMNS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,365 Underlying: Common Stock · 67,365 shares Expires 2029-10-31 F1 · kind: Represents shares acquired pursuant to vesting of Performance Stock Option (Options) that were granted to the reporting person in October 2022, 75% of which have vested based upon the satisfaction of performance criteria specified for the award at time of grant. The remaining 25% of the Options remain subject to the satisfaction of performance criteria and the reporting person's continued employment through October 31, 2026. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $65.43 | $0.00 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · derivative · entry 9 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2026-04-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: The option vested in three installments based upon the satisfaction of performance criteria specified for the award at the time of grant: 60% on April 29, 2018, 20% on April 29, 2019 and 20% on April 29, 2020. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
SaleCommon Stock | 8,984 | $361.57 | $3,248,344.88 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · nonDerivative · entry 7 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 85,576.72 F8 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $361.12 to $361.96. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
SaleCommon Stock | 15,196 | $360.79 | $5,482,564.84 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · nonDerivative · entry 6 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,560.72 F7 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $360.49 to $361.11. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
SaleCommon Stock | 15,532 | $360.09 | $5,592,917.88 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · nonDerivative · entry 5 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 109,756.72 F6 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $359.52 to $360.49. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
SaleCommon Stock | 4,234 | $359.04 | $1,520,175.36 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · nonDerivative · entry 4 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,288.72 F5 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $358.56 to $359.51. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
SaleCommon Stock | 4,971 | $358.10 | $1,780,115.10 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · nonDerivative · entry 3 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,522.72 F4 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $357.65 to $358.55. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
SaleCommon Stock | 1,083 | $356.94 | $386,566.02 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · nonDerivative · entry 2 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 134,493.72 F3 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $356.61 to $357.38. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:17 UTC |
Rutledge ElizabethChief Marketing Officer
|
Exercise / conversionCommon Stock | 50,000 | $65.43 | $3,271,500.00 |
DisclosureSEC source: 0000004962-25-000250 · form4.xml · nonDerivative · entry 1 Rutledge Elizabeth · CIK 0001730107 · Chief Marketing Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 135,576.72 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported on this Form 4 were effected pursuant to a 10b5-1 Trading Plan adopted by the reporting person on July 25, 2025. F2 · balance_after: Includes shares acquired pursuant to dividend reinvestment. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:19 UTC |
Seeger LaureenChief Legal Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 52,395 | $0.00 Strike: $148.45 | $0.00 |
DisclosureSEC source: 0000004962-25-000251 · form4.xml · derivative · entry 1 Seeger Laureen · CIK 0001357325 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,395 Underlying: Common Stock · 52,395 shares Expires 2029-10-31 F1 · kind: Represents shares acquired pursuant to vesting of Performance Stock Option (Options) that were granted to the reporting person in October 2022, 75% of which have vested based upon the satisfaction of performance criteria specified for the award at time of grant. The remaining 25% of the Options remain subject to the satisfaction of performance criteria and the reporting person's continued employment through October 31, 2026. Read SEC document |
| October 31, 2025 Filed Nov 4, 2025 21:20 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 224,551 | $0.00 Strike: $148.45 | $0.00 |
DisclosureSEC source: 0000004962-25-000252 · form4.xml · derivative · entry 3 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,551 Underlying: Common Stock · 224,551 shares Expires 2029-10-31 F3 · kind: Represents shares acquired pursuant to vesting of Performance Stock Option (Options) that were granted to the reporting person in October 2022, 75% of which have vested based upon the satisfaction of performance criteria specified for the award at time of grant. The remaining 25% of the Options remain subject to the satisfaction of performance criteria and the reporting person's continued employment through October 31, 2026. Read SEC document |
| October 23, 2025 Filed Oct 24, 2025 20:08 UTC |
Tabish DouglasChief Risk Officer
|
SaleCommon Stock | 2,515 | $355.61 | $894,359.15 |
DisclosureSEC source: 0000004962-25-000233 · form4.xml · nonDerivative · entry 1 Tabish Douglas · CIK 0002021720 · Chief Risk Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,515 Read SEC document |
| October 22, 2025 Filed Oct 24, 2025 20:06 UTC |
Pickett DenisePres., Enterprise Shared Serv.
|
SaleCommon Stock | 5,000 | $350.73 | $1,753,650.00 |
DisclosureSEC source: 0000004962-25-000232 · form4.xml · nonDerivative · entry 1 Pickett Denise · CIK 0001730101 · Pres., Enterprise Shared Serv. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,725.739 F1 · balance_after: Includes shares acquired pursuant to dividend reinvestment. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 20:18 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
OtherCommon Stock | 11,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000004962-25-000226 · form4.xml · nonDerivative · entry 3 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,980 F2 · kind: Represents shares of Company common stock transferred to the reporting person in connection with a debt previously contracted, which combined with cash, has a deemed value equal to the amount of debt discharged. Accordingly, such acquisition is exempt from Section 16(b) of the Securities Exchange Act of 1934. F2 · price: Represents shares of Company common stock transferred to the reporting person in connection with a debt previously contracted, which combined with cash, has a deemed value equal to the amount of debt discharged. Accordingly, such acquisition is exempt from Section 16(b) of the Securities Exchange Act of 1934. F1 · balance_after: Balance reflects the transfer of 17,300 shares from a Grantor Retained Annuity Trust (GRAT) to the reporting person as an annuity payment, which is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 20:18 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
GiftCommon Stock | 6,665 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-25-000226 · form4.xml · nonDerivative · entry 2 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by GRAT Disclosed balance after: 0 Read SEC document |
| October 21, 2025 Filed Oct 23, 2025 20:18 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
GiftCommon Stock | 21,450 | $0.00 | $0.00 |
DisclosureSEC source: 0000004962-25-000226 · form4.xml · nonDerivative · entry 1 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by 2020 GRAT Disclosed balance after: 0 F1 · balance_after: Balance reflects the transfer of 17,300 shares from a Grantor Retained Annuity Trust (GRAT) to the reporting person as an annuity payment, which is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:07 UTC |
Baltimore Thomas J JrDirector
|
GrantShare Equivalent Units · Derivative | 104.526 | $335.36 | $35,053.84 |
DisclosureSEC source: 0000004962-25-000193 · form4.xml · derivative · entry 1 Baltimore Thomas J Jr · CIK 0001390946 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,246.357 Underlying: Common Stock · 104.526 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:05 UTC |
Angelakis Michael JDirector
|
GrantShare Equivalent Units · Derivative | 27.023 | $335.36 | $9,062.43 |
DisclosureSEC source: 0000004962-25-000191 · form4.xml · derivative · entry 1 Angelakis Michael J · CIK 0001393014 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,019.026 Underlying: Common Stock · 27.023 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:08 UTC |
Brennan John JosephDirector
|
GrantShare Equivalent Units · Derivative | 197.549 | $335.36 | $66,250.03 |
DisclosureSEC source: 0000004962-25-000195 · form4.xml · derivative · entry 1 Brennan John Joseph · CIK 0001485472 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,940.77 Underlying: Common Stock · 197.549 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:10 UTC |
Majoras Deborah PDirector
|
GrantShare Equivalent Units · Derivative | 54.046 | $335.36 | $18,124.87 |
DisclosureSEC source: 0000004962-25-000197 · form4.xml · derivative · entry 1 Majoras Deborah P · CIK 0001483177 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,189.521 Underlying: Common Stock · 54.046 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:12 UTC |
PHILLIPS JR CHARLES EDirector
|
GrantShare Equivalent Units · Derivative | 111.82 | $335.36 | $37,499.96 |
DisclosureSEC source: 0000004962-25-000199 · form4.xml · derivative · entry 1 PHILLIPS JR CHARLES E · CIK 0001236185 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,469.474 Underlying: Common Stock · 111.82 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:14 UTC |
VASELLA DANIELDirector
|
GrantShare Equivalent Units · Derivative | 104.365 | $335.36 | $34,999.85 |
DisclosureSEC source: 0000004962-25-000201 · form4.xml · derivative · entry 1 VASELLA DANIEL · CIK 0001189152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,660.053 Underlying: Common Stock · 104.365 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:16 UTC |
WARDELL LISA WDirector
|
GrantShare Equivalent Units · Derivative | 111.82 | $335.36 | $37,499.96 |
DisclosureSEC source: 0000004962-25-000203 · form4.xml · derivative · entry 1 WARDELL LISA W · CIK 0001450092 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,276.072 Underlying: Common Stock · 111.82 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 30, 2025 Filed Oct 2, 2025 20:18 UTC |
Young Christopher DavidDirector
|
GrantShare Equivalent Units · Derivative | 119.275 | $335.36 | $40,000.06 |
DisclosureSEC source: 0000004962-25-000205 · form4.xml · derivative · entry 1 Young Christopher David · CIK 0001647655 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,741.46 Underlying: Common Stock · 119.275 shares Expires not disclosed F1 · derivative.exercise_price: Each Share Equivalent Unit reflects the value of one common share. F2 · kind: The reported Share Equivalent Units were acquired pursuant to the Directors' Deferred Compensation Plan and will be settled in cash following termination of service as a Director. F3 · derivative.exercise_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F3 · derivative.expiration_date: The Share Equivalent Units are convertible immediately upon termination of service as a Director and have no expiration date. F4 · balance_after: Includes Share Equivalent Units acquired pursuant to a dividend reinvestment feature of the Directors' Deferred Compensation Plan and/or the 2003 Share Equivalent Unit Plan for Directors. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:37 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 112,272 | $0.00 Strike: $131.68 | $0.00 |
DisclosureSEC source: 0001127602-25-021225 · form4.xml · derivative · entry 9 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 112,272 shares Expires 2030-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:37 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
OtherCommon Stock | 52,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-021225 · form4.xml · nonDerivative · entry 6 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,680 F4 · kind: On September 4, 2025, the reporting person withdrew 52,870 shares of Company common stock from a Grantor Retained Annuity Trust (GRAT) established for the benefit of himself and his beneficiaries. In exchange for the shares, the reporting person contributed to the GRAT cash and securities with a value equal to the deemed value of the shares. The withdrawal of shares from the GRAT resulted in a decrease in the number of shares the reporting person beneficially owns indirectly through the GRAT and a corresponding increase in the number of shares the reporting person beneficially owned directly. The reporting person believes that his withdrawal of shares from the GRAT constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. F4 · price: On September 4, 2025, the reporting person withdrew 52,870 shares of Company common stock from a Grantor Retained Annuity Trust (GRAT) established for the benefit of himself and his beneficiaries. In exchange for the shares, the reporting person contributed to the GRAT cash and securities with a value equal to the deemed value of the shares. The withdrawal of shares from the GRAT resulted in a decrease in the number of shares the reporting person beneficially owns indirectly through the GRAT and a corresponding increase in the number of shares the reporting person beneficially owned directly. The reporting person believes that his withdrawal of shares from the GRAT constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:37 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
OtherCommon Stock | 52,870 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-021225 · form4.xml · nonDerivative · entry 5 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by GRAT Disclosed balance after: 6,665 F4 · kind: On September 4, 2025, the reporting person withdrew 52,870 shares of Company common stock from a Grantor Retained Annuity Trust (GRAT) established for the benefit of himself and his beneficiaries. In exchange for the shares, the reporting person contributed to the GRAT cash and securities with a value equal to the deemed value of the shares. The withdrawal of shares from the GRAT resulted in a decrease in the number of shares the reporting person beneficially owns indirectly through the GRAT and a corresponding increase in the number of shares the reporting person beneficially owned directly. The reporting person believes that his withdrawal of shares from the GRAT constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. F4 · price: On September 4, 2025, the reporting person withdrew 52,870 shares of Company common stock from a Grantor Retained Annuity Trust (GRAT) established for the benefit of himself and his beneficiaries. In exchange for the shares, the reporting person contributed to the GRAT cash and securities with a value equal to the deemed value of the shares. The withdrawal of shares from the GRAT resulted in a decrease in the number of shares the reporting person beneficially owns indirectly through the GRAT and a corresponding increase in the number of shares the reporting person beneficially owned directly. The reporting person believes that his withdrawal of shares from the GRAT constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934. Read SEC document |
| September 04, 2025 Filed Sep 8, 2025 23:37 UTC |
Squeri Stephen JDirector · Chairman and CEO
|
SaleCommon Stock | 39,270 | $330.43 | $12,975,986.10 |
DisclosureSEC source: 0001127602-25-021225 · form4.xml · nonDerivative · entry 4 Squeri Stephen J · CIK 0001326109 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,810 F3 · price: The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $330.08 to $330.92. The reporting person undertakes to provide to American Express Company, any security holder of American Express Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.